Chondrial proposes venture financing

On Jan. 31, rare disease company Chondrial Therapeutics Inc. (Bala Cynwyd, Pa.) said it secured up to $22.6 million in a series A round led by Deerfield. Wake Forest Innovations' Catalyst Fund, which ...